Contrast agents: X-ray contrast agents and molecular imaging - A contradiction?

Handbook of Experimental Pharmacology

Volumn 185, Issue PART1, 2008, Pages 167-175

  Speck, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODINE;

ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PROBE; RADIATION DOSE; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; CONTRAST MEDIA; HUMANS; IODINE; MOLECULAR PROBES; RADIATION DOSAGE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52049097535     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72718-7_8     Document Type: Article

References (18)

1. BornerW,Moll E, Schneider P, Stucke K (1960) Zur Problematik der Thorotrastschaden. Klinische und radiologische Untersuchungen zum Verhalten von Thorium und seiner Zerfallsprodukte im Organismus. Rofo 93:287-297
2. Dawson P, Cosgrove DO, Grainger RG (eds) (1999) Textbook of contrast media. Isis Medical Media, Oxford
3. Difazio LT, Singhvi SM, Heald AF, McKinstry DN, Brosman SA, Gillenwater JY, Willard DA (1978) Pharmacokinetics of iodamide in normal subjects and in patients with renal impairment. J Clin Pharmacol 18:35-41
4. Krause W, Schuhmann-Gampieri G (1998) Pharmacokinetics of contrast media. In: Dawson P, Clauss W (eds) Contrast media in practice. Springer, Berlin Heidelberg New York, pp 31-39
5. Leander P, Hoglund P, Kloster Y (1998) New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety. Acad Radiol 5(Suppl 1):S6-S8
6. Lin SK, Moss AA, Riegelman S (1977) Iodipamide kinetics: Capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci 66:1670-1674
7. Martling U, Mattsson A, Travis LB, Holm LE, Hall P (1999) Mortality after long-term exposure to radioactive Thorotrast: a forty-year follow-up survey in Sweden. Radiat Res 151:293-299
8. Mitsutomo O (1930) Klinische Anwendung der Lienographie, einer neuen Methode zur rontgenologischen Darstellung von Milz und Leber. Rofo 41:892-898
9. MutzelW,Wegener OH, Souchon R,Weinmann H-J (1982) Water-soluble contrast agents for computed tomography of the liver: experimental studies in dog. In: Amiel M, Moreau JF (eds) Contrast media in radiology Appraisal and prospects. Springer, Berlin Heidelberg New York, pp 320-323
10. Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C (2000) The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 86(Suppl):6H-11H
11. Schmiedl U, Schmoll K, Horn J, Speck U, Freeny P (1994) Imaging of exocrine pancreatic function investigation of the biovailability of weak organic acids as potential pancreatic contrast agents for computed tomography. Invest Radiol 29:689-694
12. Schmitz SA, Haberle JH, Balzer T, Shamsi K, Boese-Landgraf J, Wolf K-J (1997) Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOBDTPA. Radiology 2002:399-405
13. Thakur M, Lentle BC (2005) Report of a summit on molecular imaging. Radiology 236:753-755
14. Urich K, Speck U (1991) Biliary excretion of contrast media. Progr Pharmacol Clin Pharmacol 8:307-322
15. Urich K (1995) Successes and failures in the development of contrast media. Blackwell, Berlin
16. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Research 49:6449-6465
17. Violante MR, Mare K, Fischer HW (1981) Biodistribution of a particulate hepatolienographic CT contrast agent: A study of iodipamide ethyl ester in the rat. Invest Radiol 16:40-45
18. Weichert JP, Lee FT, Chosy SG, Longino MA, Kuhlman JE, Helsey DE, Leverson GE (2000) Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits. Radiology 216:865-871